Works by Murphy, Sabina


Results: 98
    1

    Privacy-aware multi-institutional time-to-event studies.

    Published in:
    PLoS Digital Health, 2022, v. 1, n. 9, p. 1, doi. 10.1371/journal.pdig.0000101
    By:
    • Späth, Julian;
    • Matschinske, Julian;
    • Kamanu, Frederick K.;
    • Murphy, Sabina A.;
    • Zolotareva, Olga;
    • Bakhtiari, Mohammad;
    • Antman, Elliott M.;
    • Loscalzo, Joseph;
    • Brauneck, Alissa;
    • Schmalhorst, Louisa;
    • Buchholtz, Gabriele;
    • Baumbach, Jan
    Publication type:
    Article
    2

    Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 300, n. 1, p. 71, doi. 10.1001/jama.300.1.71
    By:
    • O'Donoghue, Michelle;
    • Boden, William E.;
    • Braunwald, Eugene;
    • Cannon, Christopher P.;
    • Clayton, Tim C.;
    • de Winter, Robbert J.;
    • Fox, Keith A. A.;
    • Lagerqvist, Bo;
    • McCullough, Peter A.;
    • Murphy, Sabina A.;
    • Spacek, Rudolf;
    • Swahn, Eva;
    • Wallentin, Lars;
    • Windhausen, Fons;
    • Sabatine, Marc S.
    Publication type:
    Article
    3

    Diabetes and Mortality Following Acute Coronary Syndromes.

    Published in:
    JAMA: Journal of the American Medical Association, 2007, v. 298, n. 7, p. 765, doi. 10.1001/jama.298.7.765
    By:
    • Donahoe, Sean M.;
    • Stewart, Garrick C.;
    • McCabe, Carolyn H.;
    • Mohanavelu, Satishkumar;
    • Murphy, Sabina A.;
    • Cannon, Christopher P.;
    • Antman, Elliott M.
    Publication type:
    Article
    4

    Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.

    Published in:
    2007
    By:
    • Morrow DA;
    • Scirica BM;
    • Karwatowska-Prokopczuk E;
    • Murphy SA;
    • Budaj A;
    • Varshavsky S;
    • Wolff AA;
    • Skene A;
    • McCabe CH;
    • Braunwald E;
    • MERLIN-TIMI 36 Trial Investigators;
    • Morrow, David A;
    • Scirica, Benjamin M;
    • Karwatowska-Prokopczuk, Ewa;
    • Murphy, Sabina A;
    • Budaj, Andrzej;
    • Varshavsky, Sergei;
    • Wolff, Andrew A;
    • Skene, Allan;
    • McCabe, Carolyn H
    Publication type:
    journal article
    5
    6
    7

    Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics: The PCI-CLARITY Study.

    Published in:
    JAMA: Journal of the American Medical Association, 2005, v. 294, n. 10, p. 1224, doi. 10.1001/jama.294.10.1224
    By:
    • Sabatine, Marc S.;
    • Cannon, Christopher P.;
    • Gibson, C. Michael;
    • López-Sendón, Jose L.;
    • Montalescot, Gilles;
    • Theroux, Pierre;
    • Lewis, Basil S.;
    • Murphy, Sabina A.;
    • McCabe, Carolyn H.;
    • Braunwald, Eugene
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.

    Published in:
    Diabetes Care, 2022, v. 45, n. 10, p. 2350, doi. 10.2337/dc22-0382
    By:
    • Mosenzon, Ofri;
    • Raz, Itamar;
    • Wiviott, Stephen D.;
    • Schechter, Meir;
    • Goodrich, Erica L.;
    • Yanuv, Ilan;
    • Rozenberg, Aliza;
    • Murphy, Sabina A.;
    • Zelniker, Thomas A.;
    • Langkilde, Anna Maria;
    • Gause-Nilsson, Ingrid A.M.;
    • Fredriksson, Martin;
    • Johansson, Peter A.;
    • Wilding, John P.H.;
    • McGuire, Darren K.;
    • Bhatt, Deepak L.;
    • Leiter, Lawrence A.;
    • Cahn, Avivit;
    • Dwyer, Jamie P.;
    • Heerspink, Hiddo J.L.
    Publication type:
    Article
    20
    21
    22

    The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.

    Published in:
    2021
    By:
    • Mosenzon, Ofri;
    • Wiviott, Stephen D.;
    • Heerspink, Hiddo J.L.;
    • Dwyer, Jamie P.;
    • Cahn, Avivit;
    • Goodrich, Erica L.;
    • Rozenberg, Aliza;
    • Schechter, Meir;
    • Yanuv, Ilan;
    • Murphy, Sabina A.;
    • Zelniker, Thomas A.;
    • Gause-Nilsson, Ingrid A.M.;
    • Langkilde, Anna Maria;
    • Fredriksson, Martin;
    • Johansson, Peter A.;
    • Bhatt, Deepak L.;
    • Leiter, Lawrence A.;
    • McGuire, Darren K.;
    • Wilding, John P.H.;
    • Sabatine, Marc S.
    Publication type:
    journal article
    23
    24
    25
    26
    27

    Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial.

    Published in:
    European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. 1216, doi. 10.1093/eurjpc/zwae090
    By:
    • Zimerman, Andre;
    • Wiviott, Stephen D;
    • Park, Jeong-Gun;
    • Murphy, Sabina A;
    • Ran, Xinhui;
    • Bramson, Candace R;
    • Curto, Madelyn;
    • Ramos, Vesper;
    • Jevne, Alexandra;
    • Kuder, Julia F;
    • Verma, Subodh;
    • Wojakowski, Wojtek;
    • Terra, Steven G;
    • Sabatine, Marc S;
    • Bergmark, Brian A;
    • Marston, Nicholas A
    Publication type:
    Article
    28

    The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1226, doi. 10.1007/s00125-021-05399-2
    By:
    • O'Donoghue, Michelle L.;
    • Kato, Eri T.;
    • Mosenzon, Ofri;
    • Murphy, Sabina A.;
    • Cahn, Avivit;
    • Herrera, Marisol;
    • Tankova, Tsvetalina;
    • Šmahelová, Alena;
    • Merlini, Piera;
    • Gause-Nilsson, Ingrid;
    • Langkilde, Anna Maria;
    • McGuire, Darren K.;
    • Wilding, John P. H.;
    • Leiter, Larry A.;
    • Bhatt, Deepak L.;
    • Raz, Itamar;
    • Sabatine, Marc S.;
    • Wiviott, Stephen D.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36

    Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials.

    Published in:
    European Heart Journal, 2004, v. 25, n. 22, p. 1998, doi. 10.1016/j.ehj.2004.08.016
    By:
    • Gibson, C. Michael;
    • Dumaine, Raphaelle L.;
    • Gelfand, Eli V.;
    • Murphy, Sabina A.;
    • Morrow, David A.;
    • Wiviott, Stephen D.;
    • Giugliano, Robert P.;
    • Cannon, Christopher P.;
    • Antman, Elliott M.;
    • Braunwald, Eugene
    Publication type:
    Article
    37
    38
    39
    40

    303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial.

    Published in:
    Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-303-OR
    By:
    • RAZ, ITAMAR;
    • WIVIOTT, STEPHEN D.;
    • HEERSPINK, HIDDO L.;
    • DWYER, JAMIE P.;
    • CAHN, AVIVIT;
    • GOODRICH, ERICA L.;
    • MURPHY, SABINA;
    • ROZENBERG, ALIZA;
    • YANUV, ILAN;
    • WILDING, JOHN;
    • LEITER, LAWRENCE A.;
    • BHATT, DEEPAK L.;
    • MCGUIRE, DARREN K.;
    • MA, RONALD C.;
    • TANKOVA, TSVETALINA;
    • FREDRIKSSON, MARTIN;
    • GAUSE-NILSSON, INGRID A.;
    • LANGKILDE, ANNA MARIA;
    • SABATINE, MARC S.;
    • MOSENZON, OFRI
    Publication type:
    Article
    41

    1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58.

    Published in:
    Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1101-P
    By:
    • CAHN, AVIVIT;
    • WIVIOTT, STEPHEN D.;
    • MOSENZON, OFRI;
    • MURPHY, SABINA;
    • GOODRICH, ERICA L.;
    • YANUV, ILAN;
    • ROZENBERG, ALIZA;
    • WILDING, JOHN;
    • LEITER, LAWRENCE A.;
    • BHATT, DEEPAK L.;
    • MCGUIRE, DARREN K.;
    • LITWAK, LEON;
    • KOOY, ADRIAAN;
    • GAUSE-NILSSON, INGRID A.;
    • FREDRIKSSON, MARTIN;
    • LANGKILDE, ANNA MARIA;
    • SABATINE, MARC S.;
    • RAZ, ITAMAR
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1026, doi. 10.1002/ejhf.2073
    By:
    • Zelniker, Thomas A.;
    • Morrow, David A.;
    • Mosenzon, Ofri;
    • Goodrich, Erica L.;
    • Jarolim, Petr;
    • Murphy, Sabina A.;
    • Bhatt, Deepak L.;
    • Leiter, Lawrence A.;
    • McGuire, Darren K.;
    • Wilding, John;
    • Bode, Christoph;
    • Lewis, Basil S.;
    • Gause‐Nilsson, Ingrid;
    • Langkilde, Anna Maria;
    • Fredriksson, Martin;
    • Raz, Itamar;
    • Sabatine, Marc S.;
    • Wiviott, Stephen D.
    Publication type:
    Article
    48
    49
    50